The expansion places the company on one of snack retail's most competitive shelves
The expansion places the company on one of snack retail's most competitive shelves.
The expansion places the company on one of snack retail's most competitive shelves.
Medici Brands revealed Rowdy as its third consumer brand in September 2026, backed by a $250 million Series B at a reported $2.25 billion valuation, per Stack3d.
Backed by a $250M Series B, Medici Brands is expanding its David Protein and HallPass portfolio into salty snacks with Rowdy, a chip brand expected to launch before year's end.
Greenoaks and Valor Equity Partners co-led the Series B for the David Protein parent, which is projecting more than $300 million in 2026 revenue as it expands into confectionery and new brands.